Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
A Multi-Center Trial of the ProLung Test™
NCT01566682 · View on ClinicalTrials.gov ↗
Study Summary
The primary Study hypothesis is that the ProLung Test will demonstrate safety and efficacy in the risk stratification of patients with pulmonary lesions identified by CT that are suspicious for lung cancer. A statistically significant result will indicate that patients with a high ProLung Test result have a greater risk of developing lung cancer than patients with a low test result. There are three Specific Aims of this study: 1. Optimize and confirm the stability of the ProLung Test risk-stratification algorithm in patients with a diagnosis. 2. Externally validate the efficacy of the ProLung Test risk-stratification algorithm by comparing the test result to the conclusive patient diagnosis. 3. Assess the safety and tolerability of the ProLung Test procedures. Study Design This Study consists of two distinct phases, Stabilization and Validation. The Study will collect data from multiple sites (3 to 12), and each site may enroll patients and collect data for the Stabilization and Validation Phases with a minimum of three sites for the Validation Phase.
Conditions Studied
Study Locations (15)
California
- UCLA Medical Center — Los Angeles
- UCSD Medical Center — San Diego
- Stanford University Medical Center — Stanford
Minnesota
- University of Minnesota Masonic Cancer Center — Minneapolis
- Mayo Clinic — Rochester
Texas
- MD Anderson Cancer Center — Houston
- Providence Health Center — Waco
Utah
- Intermountain Healthcare — Murray
- Huntsman Cancer Institute — Salt Lake City
Illinois
- Loyola University Medical Center — Maywood
Maryland
- Greater Baltimore Medical Center — Towson
Massachusetts
- Beth Israel Deaconess Medical Center — Boston
Michigan
- Henry Ford Medical Center — Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 420 participants |
| Start Date | 2012-10 |
| Est. Completion | 2019-03 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01566682
The ClinicalTrials.gov registry entry for NCT01566682 describes a study currently listed as completed. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 420 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fresh Medical Laboratories, which has 1 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 2 conditions, with Multiple Pulmonary Nodules appearing as the primary indexed condition, and to 0 interventions. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT01566682 reports 15 study locations spanning 10 distinct geographic areas — top geographies include California, Minnesota, Texas. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT01566682 about?
NCT01566682 is a clinical study titled "A Multi-Center Trial of the ProLung Test™". The primary Study hypothesis is that the ProLung Test will demonstrate safety and efficacy in the risk stratification of patients with pulmonary lesions identified by CT that are suspicious for lung cancer. A statistically significant result will indicate that patients with a high ProLung Test resul...
What is the current status of trial NCT01566682?
This trial is currently completed. The enrollment target is 420 participants. The study started on 2012-10. Estimated completion is 2019-03.
What conditions does trial NCT01566682 study?
This clinical trial studies the following conditions: Multiple Pulmonary Nodules, Solitary Pulmonary Nodule. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
Who is sponsoring clinical trial NCT01566682?
This trial is sponsored by Fresh Medical Laboratories, which has 1 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT01566682 being conducted?
This trial has 15 study locations across California, Illinois, Maryland, Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.